Investors

Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.

We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.

Recent News

Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update

– Significantly strengthened balance sheet and cash position – Continued FDA Warning Letter remediation efforts – Antici...

Learn More

Teligent Announces Hiring of Chief Financial Officer

BUENA, N.J. , April 15, 2021 (GLOBE NEWSWIRE) -- Teligent , Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jer...

Learn More

Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors

Experienced Board Member and Investment Executive Joins Teligent, Effective Immediately BUENA, N.J. , Feb. 23, 2021 /PRN...

Learn More

Investor Overview

There are no items to display.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.